Tag: Sanofi
Sanofi: answers in sight
[ad_1] By Claude Leguilloux Published on 04/10/2024 at 11:23 a.m. Photo credit © Sanofi / Regeneron (Boursier.com)…
Sanofi: sale of an anti-anemic drug to the Italian Recordati
[ad_1] (CercleFinance.com) – The Italian pharmaceutical group Recordati formalized an agreement on Friday under which it will buy its anemia treatment Enjaymo from Sanofi for an amount that could exceed…
Sanofi, GSK and CSL called to increase supply of avian flu vaccines in the United States – 10/04/2024 at 5:07 p.m.
[ad_1] ((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto)) (Added new source of supply to paragraph 1, added details throughout the document) GSK GSK.L , Sanofi SASY.PA and CSL Ltd…
Sanofi: Sale of an anti-anemic drug to Italian Recordati
[ad_1] Also read (CercleFinance.com) – The Italian pharmaceutical group Recordati formalized an agreement on Friday under which it will buy its anemia treatment Enjaymo from Sanofi for an amount that…
Sanofi: approval of Dupixent in the United States for the treatment of COPD
[ad_1] By Alexandra Saintpierre Published on 09/30/2024 at 7:23 a.m. Photo credit © Sanofi / Regeneron (Boursier.com)…
Sanofi: approval in COPD in the United States – 09/27/2024 at 3:57 p.m.
[ad_1] (CercleFinance.com) – Sanofi announces that the US FDA has approved its Dupixent for the adjunctive maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an…
Sanofi: the fog lifts a little over the future of Doliprane
[ad_1] Boxes of Doliprane on sale in a pharmacy in France, October 23, 2023 (AFP/Archives/SEBASTIEN BOZON) Sanofi has promised a decision “in the coming weeks” on the future of Opella,…
Sanofi: Dupixent approved in China for the treatment of COPD
[ad_1] (AOF) – Dupixent is the first biological drug approved in China for the treatment of COPD. This is what Sanofi announces (-0.10% to 102.22 euros), specifying that COPD (chronic…
Sanofi: bets on an American biotech
[ad_1] By Jean-Baptiste André Published on 09/23/2024 at 4:09 p.m. Photo credit © Sanofi Corporate (Boursier.com) —…
Sanofi: sale of consumer healthcare division takes shape
[ad_1] (AOF) – Sanofi (-0.39% at 103.28 euros) has received two takeover offers for its consumer healthcare division, according to Bloomberg. These offers are said to come from private equity…
SANOFI: NO FINAL DECISION HAS BEEN MADE ON THE SPLIT-UP OF THE CONSUMER HEALTHCARE BUSINESS
[ad_1] Published on 09/23/2024 at 4:38 p.m. SANOFI-NO FINAL DECISION HAS BEEN MADE ON SPLITTING OF CONSUMER HEALTHCARE BUSINESS-CEO IN INTERVIEW …
SANOFI HAS CONFIDENTIAL RESEARCH PROGRAMS ON OBESITY TREATMENTS
[ad_1] Published on 09/23/2024 at 4:40 p.m. SANOFI HAS CONFIDENTIAL RESEARCH PROGRAMS ON OBESITY TREATMENTS AND MAKES INVESTMENTS IN THIRD-PARTY ENTITIES-DG IN…